NCT00002835: Combination Chemotherapy in Treating Patients With Lymphoma |
|
|
| Completed | 3 | 116 | US | Bleomycin Sulfate (BLM), Blenoxane, BLM, Filgrastim (G-CSF), G-CSF, Neupogen, Recombinant Interferon Alfa, Carmustine, BiCNU, BiCNUI, Cisplatin (CDDP), Platinol, Platinol-AQ, Cyclophosphamide, Cytoxan, Neosar, Cytarabine (ARA-C), ARA-C, Cytosar, DepotCyt, Cytosine arabinosine hydrochloride, Etoposide (VP-16), VePesid, Idarubicin, Idamycin, Ifosfamide, Ifex, Leucovorin Calcium, Leucovorin, Citrovorum, Wellcovorin, Melphalan, Alkeran, Methotrexate, Methylprednisolone, Depo-Medrol, Medrol, Solu-Medrol, mitoxantrone hydrochloride (DHAD), mitoxantrone, Novantrone, Vincristine Sulfate, Peripheral Blood Stem Cell Transplantation, autologous peripheral blood stem cells, PBSC, Radiation Therapy, RT | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Lymphoma | 02/04 | 02/04 | | |
